Clinical Trials Logo

Filter by:
NCT ID: NCT05736809 Active, not recruiting - Clinical trials for Sports Physical Therapy

Calcaneal Low Dye Taping Plantar Fascial Stretching and Sham Taping in Football Players

Start date: December 19, 2022
Phase: N/A
Study type: Interventional

Showing the effect of calcaneal Low-dye Taping on acute planter heel pain and functional activity level in football players.

NCT ID: NCT05724394 Active, not recruiting - Eating Disorders Clinical Trials

Feasibility Trial of Getting Better Bite by Bite for Eating Disorders

CaGBBB
Start date: April 28, 2023
Phase: N/A
Study type: Interventional

This is a mixed method feasibility randomized controlled trial to explore the feasibility and acceptability of therapist delivered, culturally adapted, manualized Ca-GBBB intervention for Eating Disorders (EDs) - Bulimia Nervosa (BN) and Bing Eating Disorder (BED) in Pakistan.

NCT ID: NCT05709925 Active, not recruiting - Low Back Pain Clinical Trials

Effects of Instrument Assisted Soft Tissue Mobilization in Patients With Chronic Mechanical Low Back Pain

Start date: August 11, 2022
Phase: N/A
Study type: Interventional

This study is a Randomized Control Trial in which participants aged 18-50 years having diagnosed chronic mechanical low back pain will be recruited into two groups. Group A will be receiving myofascial release using stripping technique whereas, Group B will be receiving Instrument Assisted Soft Tissue Mobilization using long bar tool. Afterwards, post-treatment stretching would be performed in both the groups. Final assessment of pain, range of motion and disability will be done on last treatment session.

NCT ID: NCT05680506 Active, not recruiting - Clinical trials for Chronic Low-back Pain

Effects of Pain Neuroscience Education With Conventional Physical Therapy in Patients With Chronic Low Back Pain

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

Low back pain is currently considered to be the most common cause of disability.When low back pain occurs sensitivity of body increases which decreases overall body activity.Physical inactivity negatively effects recovery from chronic low back pain.Patients with chronic low back pain experience psychological anxiety and depression which leads to fear of pain and movement.There are various treatment options for chronic low back pain.But most treatment options deal with biomedical aspect of disease.Pain neuroscience education deals with psychological aspect of disease.By combining both treatment options we will be able to evaluate the combined biopsychosocial aspect of treatment.This study will mainly focus on the education of patients regarding neuroscience be hind their chronic low back pain.

NCT ID: NCT05680493 Active, not recruiting - Low Back Pain Clinical Trials

Comparison of Dry Needling and Manual Pressure Release for Managing Low Back Pain

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

This study will compare the effect of dry needling and manual pressure in patients having low back pain in terms of pain and disability. There will be two groups ; experimental and control. Half of study group will receive dry needling session along with hot pack. Half of study group will receive manual pressure technique along with hot pack.

NCT ID: NCT05667974 Active, not recruiting - Prevention Clinical Trials

A Study to Evaluate a PIKA Rabies Vaccine(Vero Cell)for Human Use,Freeze-dried

Start date: September 22, 2023
Phase: Phase 3
Study type: Interventional

This is a phase III, randomized, comparator-controlled, double-blind, multicenter study to evaluate lot-to-lot consistency of three lots of a PIKA Rabies Vaccine, immunogenicity and safety in healthy adults using a post-exposure prophylaxis schedule. It is also the aim of this study to evaluate non-inferiority and superiority of the PIKA Rabies Vaccine compared to the rabies vaccine comparator ChiroRab.

NCT ID: NCT05666648 Active, not recruiting - Pain, Postoperative Clinical Trials

Sitz Bath vs no Sitz Bath in Acute Anal Fissure Treatment

Start date: January 1, 2019
Phase:
Study type: Observational [Patient Registry]

To compare the efficacy of 'sitz bath' and 'no sitz bath' treatment in terms of pain improvement, rate of cure and fissure healing in Acute Anal Fissure.

NCT ID: NCT05656352 Active, not recruiting - Clinical trials for Pregnancy, High Risk

Validation of a Non-invasive Hemoglobin Measurement Device in Pregnancy and Postpartum in Kenya, Pakistan, and Zambia

Start date: September 22, 2022
Phase:
Study type: Observational

Accurate, precise, and comparable hemoglobin measurements is of great importance, both for clinical value in diagnosing anemia and ensuring pregnant women receive appropriate treatment. The Masimo Total Hemoglobin SpHb® is a continuous and non-invasive handheld device with an optical sensor placed on the finger that measures hemoglobin levels using pulse oximetry. The objective of this study is evaluate the compatibility of hemoglobin measurements between SpHb and the gold standard laboratory-based assessment (complete blood count assessed via five-part autoanalyzer) throughout the course of pregnancy and at six weeks postpartum.

NCT ID: NCT05644860 Active, not recruiting - Clinical trials for Nanotechnology, Dental Materials, Composites

Nano Composites and Light Cure Composites - A Comparative Assessment of Bond Failure Rates

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

This randomized clinical trial is aimed to evaluate the bond failure rates of the brackets bonded with nano-hybrid composites (Filtek Z250) to that of conventional composites (Transbond XT)

NCT ID: NCT05636319 Active, not recruiting - COVID-19 Clinical Trials

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine

Start date: November 23, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine (ABO1020) in Healthy Subjects Aged 18 Years and Older Who Have Completed the Full Vaccination